1. Home
  2. Labeler Index
  3. Taiho Pharmaceutical Co., Ltd.
  4. 64842-0727
  5. NDC Package Code: 64842-0727-9 Inqovi

NDC Package 64842-0727-9 Inqovi

Cedazuridine And Decitabine Tablet, Film Coated Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
64842-0727-9
Package Description:
1 BLISTER PACK in 1 CARTON / 5 TABLET, FILM COATED in 1 BLISTER PACK
Product Code:
64842-0727
Proprietary Name:
Inqovi
Non-Proprietary Name:
Cedazuridine And Decitabine
Substance Name:
Cedazuridine; Decitabine
Usage Information:
INQOVI is indicated for treatment of adult patients with myelodysplastic syndromes (MDS), including previously treated and untreated, de novo and secondary MDS with the following French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and chronic myelomonocytic leukemia [CMML]) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups.
11-Digit NDC Billing Format:
64842072709
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 2384457 - cedazuridine 100 MG / decitabine 35 MG Oral Tablet
  • RxCUI: 2384458 - {5 (cedazuridine 100 MG / decitabine 35 MG Oral Tablet) } Pack
  • RxCUI: 2384458 - cedazuridine 100 MG / decitabine 35 MG (5) Oral Tablet Pack
  • RxCUI: 2384464 - INQOVI 35 MG / 100 MG Oral Tablet
  • RxCUI: 2384464 - cedazuridine 100 MG / decitabine 35 MG Oral Tablet [Inqovi]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Taiho Pharmaceutical Co., Ltd.
    Dosage Form:
    Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • CEDAZURIDINE 100 mg/1
  • DECITABINE 35 mg/1
    • Pharmacologic Class(es):
  • Nucleic Acid Synthesis Inhibitors - [MoA] (Mechanism of Action)
  • Nucleoside Metabolic Inhibitor - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    NDA212576
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    07-07-2020
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 64842-0727-9?

    The NDC Packaged Code 64842-0727-9 is assigned to a package of 1 blister pack in 1 carton / 5 tablet, film coated in 1 blister pack of Inqovi, a human prescription drug labeled by Taiho Pharmaceutical Co., Ltd.. The product's dosage form is tablet, film coated and is administered via oral form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 64842-0727 included in the NDC Directory?

    Yes, Inqovi with product code 64842-0727 is active and included in the NDC Directory. The product was first marketed by Taiho Pharmaceutical Co., Ltd. on July 07, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 64842-0727-9?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 64842-0727-9?

    The 11-digit format is 64842072709. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-164842-0727-95-4-264842-0727-09